| Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivo LH Pao, OYP Hu, HY Fan, CC Lin, LC Liu, PW Huang The American journal of Chinese medicine 40 (01), 57-73, 2012 | 66 | 2012 |
| Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexes RR Moody, MC Lo, JL Meagher, CC Lin, NO Stevers, SL Tinsley, I Jung, ... Journal of Biological Chemistry 293 (6), 2125-2136, 2018 | 59 | 2018 |
| Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity AB Hanker, BP Brown, J Meiler, A Marín, HS Jayanthan, D Ye, CC Lin, ... Cancer cell 39 (8), 1099-1114. e8, 2021 | 52 | 2021 |
| Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer DS Lichao Sun, Joseph Burnett1, Mari Gasparyan, Fangying Xu, Hui Jiang ... Oncotarget, 2016 | 44 | 2016 |
| Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer A Servetto, R Kollipara, L Formisano, CC Lin, KM Lee, DR Sudhan, ... Clinical Cancer Research 27 (15), 4379-4396, 2021 | 40 | 2021 |
| Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer K Lee, AL Guerrero-Zotano, A Servetto, DR Sudhan, CC Lin, L Formisano, ... Nature communications 11 (1), 5488, 2020 | 39 | 2020 |
| Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer CC Lin, MC Lo, R Moody, H Jiang, R Harouaka, N Stevers, S Tinsley, ... Cancer letters 438, 165-173, 2018 | 39 | 2018 |
| Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells CC Lin, MC Lo, RR Moody, NO Stevers, SL Tinsley, D Sun Oncology reports 39 (6), 3041-3047, 2018 | 23 | 2018 |
| Evaluation of Chinese-Herbal-Medicine-Induced Herb-Drug Interactions: Focusing on Organic Anion Transporter 1 CC Lin, HY Fan, CW Kuo, LH Pao Evidence-Based Complementary and Alternative Medicine, 2012 | 19 | 2012 |
| R26R-GR: A Cre-activable dual fluorescent protein reporter mouse YT Chen, MS Tsai, TL Yang, AT Ku, KH Huang, CY Huang, FJ Chou, ... PloS one 7 (9), e46171, 2012 | 17 | 2012 |
| Epigenetic repression of STING by MYC promotes immune evasion and resistance to immune checkpoint inhibitors in triple-negative breast cancer K Lee, CC Lin, A Servetto, J Bae, V Kandagatla, D Ye, GM Kim, ... Cancer immunology research 10 (7), 829-843, 2022 | 16 | 2022 |
| Combined p53-and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer M Gasparyan, MC Lo, H Jiang, CC Lin, D Sun Journal of Biological Chemistry 295 (34), 12188-12202, 2020 | 16 | 2020 |
| Simultaneous determination of triazolam and its metabolites in human plasma by liquid chromatography–tandem mass spectrometry RN Pan, CC Lin, PW Huang, CH Hsiong, LH Pao | 14 | 2008 |
| Development and validation of a liquid chromatography–tandem mass spectrometry method for simultaneous quantification of p-aminohippuric acid and inulin in rat plasma for renal … CC Lin, CW Kuo, LH Pao | 11 | 2010 |
| Determination of p-aminohippuric acid in rat plasma by liquid chromatography-tandem mass spectrometry HY Fan, CC Lin, LH Pao | 5 | 2010 |
| PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer CC Lin, TC Chang, Y Wang, L Guo, Y Gao, E Bikorimana, A Lemoff, ... Nature communications 15 (1), 2287, 2024 | 2 | 2024 |
| Corrigendum to “Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer”[Canc. Lett. 438 (2018, Dec 1) 165–173](Cancer Letters (2018) 438 (165–173 … CC Lin, MC Lo, R Moody, H Jiang, R Harouaka, N Stevers, S Tinsley, ... Cancer Letters 480, 51, 2020 | 2 | 2020 |
| Co-Occurring Gain-of-Function Mutations in HER2 and HER3 Modulate HER2/HER3 Activation, Breast Cancer Progression, and HER2 Inhibitor Sensitivity A Hanker, S Harikrishna, A Marin, D Ye, CC Lin, DR Sudhan, H Akamatsu, ... Breast Cancer Progression, and HER2 Inhibitor Sensitivity, 2020 | 2 | 2020 |
| Identification of MLK4 as a novel regulator of cancer stem cells in triple-negative breast cancer CC Lin, MC Lo, R Moody, N Stevers, S Tinsley, M Gasparyan, M Wicha, ... Cancer Research 78 (13_Supplement), 2004-2004, 2018 | 2 | 2018 |
| Identifying CDCA7 as a novel regulator of tumor-initiating cells in triple-negative breast cancer CC Lin, MC Lo, R Moody, N Stevers, S Tinsley, M Wicha, D Sun Cancer Research 77 (13_Supplement), 4767-4767, 2017 | 2 | 2017 |
